The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Aryl hydrocarbon receptor ligand production by the gut microbiota is decreased in celiac disease leading to intestinal inflammation
Open accessAbstract
, or pharmacological stimulation using 6-formylindolo (3,2-b) carbazole (Ficz) decreased immunopathology in NOD/DQ8 mice exposed to gluten. We then determined AhR ligand production by the fecal microbiota and AhR activation in patients with active celiac disease compared to nonceliac control individuals. Patients with active celiac disease demonstrated reduced AhR ligand production and lower intestinal AhR pathway activation. These results highlight gut microbiota-dependent modulation of the AhR pathway in celiac disease and suggest a new therapeutic strategy for treating this disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the importance of the GM’s ability to metabolize tryptophan into aryl hydrocarbon receptor ligands and, therefore, modulate gut inflammation, was demonstrated in patients with celiac disease (202).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [202]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760
Proteobacteria: Microbial signature of dysbiosis in gut microbiota
Shin, N.-R., Whon, T. W., & Bae, J.-W. (2015) · Trends in Biotechnology · doi:10.1016/j.tibtech.2015.06.011 · Cited by 3,954
Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis
Yano, J. M., Yu, K., Donaldson, G. P., Shastri, G. G., Ann, P., Ma, L., Nagler, C. R., Ismagilov, R. F., Mazmanian, S. K., & Hsiao, E. Y. (2015) · Cell · doi:10.1016/j.cell.2015.02.047 · Cited by 3,614
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
Agus, A., Planchais, J., & Sokol, H. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.003 · Cited by 3,180
Zelante, T., Iannitti, R. G., Cunha, C., De Luca, A., Giovannini, G., Pieraccini, G., Zecchi, R., D’Angelo, C., Massi-Benedetti, C., Fallarino, F., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.003 · Cited by 2,614
Innate lymphoid cells — a proposal for uniform nomenclature
Spits, H., Artis, D., Colonna, M., Diefenbach, A., Disanto, J. D., Eberl, G., Koyasu, S., Locksley, R., McKenzie, A., Mebius, R., et al. (2013) · Nature reviews. Immunology · doi:10.1038/nri3365 · Cited by 2,380
Role of the gut microbiota in immunity and inflammatory disease
Kamada, N., Seo, S.-U., Chen, G. Y., & Núñez, G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3430 · Cited by 2,256
Microbial tryptophan catabolites in health and disease
Roager, H. M., & Licht, T. R. (2018) · Nature Communications · doi:10.1038/s41467-018-05470-4 · Cited by 2,236
Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R. D., Shanahan, F., Dinan, T. G., & Cryan, J. F. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.77 · Cited by 1,893
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–179 of 179
Benech, N., Rolhion, N., & Sokol, H. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.01.059 · Cited by 13
Fournier, E., Ratel, J., Denis, S., LEVEQUE, M., Ruiz, P., Mazal, C., Amiard, F., Edely, M., Bézirard, V., Gaultier, E., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4229664 · Cited by 13
You, X., Wang, L., Wang, H., Xu, Y., Chen, Y., Xu, H., Ji, X., Ma, X., & Xu, X. (2024) · iScience · doi:10.1016/j.isci.2024.110849 · Cited by 12
Pyroptosis the Emerging Link Between Gut Microbiota and Multiple Sclerosis
Fan, H., Shen, R., Yan, J., Bai, Y., Fu, Q., Shi, X., Du, G., & Wang, D. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s489454 · Cited by 12
Liu, M., Fan, G., Meng, L., Yang, K., & Liu, H. (2024) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2300343 · Cited by 10
Huang, F. (2024) · Biomedicines · doi:10.3390/biomedicines12122912 · Cited by 13
Investigating the Impact of Vitamin A and Amino Acids on Immune Responses in Celiac Disease Patients
Fallah, S., Asri, N., Nikzamir, A., Ahmadipour, S., Sadeghi, A., Rostami, K., & Rostami‐Nejad, M. (2024) · Diseases · doi:10.3390/diseases12010013 · Cited by 10
“According to reports, a high TRP diet increases the production of aryl hydrocarbon receptor (AhR) ligands and activates this pathway, which is responsible for controlling inflammation and safeguarding the gut barrier; it also decreases gluten immunopathology in mice expressing the DQ8 gene [40,41].”
BackgroundLamas, B., Breyner, N. M., Malaisé, Y., Wulczynski, M., Galipeau, H. J., Gaultier, E., Cartier, C., Verdu, E. F., & Houdeau, É. (2024) · Environmental Health Perspectives · doi:10.1289/ehp12758 · Cited by 10
Nurturing gut health: role of m6A RNA methylation in upholding the intestinal barrier
Wang, S., Yang, Y., Jiang, X., Zheng, X., Wei, Q., Dai, W., & Zhang, X. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02043-x · Cited by 9
Asgari, F., Khodadoust, M., Nikzamir, A., Jahani‐Sherafat, S., Rezaei–Tavirani, M., & Rostami‐Nejad, M. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1354 · Cited by 9
“60 A report has been published regarding the enhanced expression of IDO throughout the small intestine of individuals with CeD, which can be a key element in the mechanism that causes tolerance to dietary antigens.”
BackgroundZhao, C., Bao, L., Shan, R., Zhao, Y., Wu, K., Shang, S., Li, H., Liu, Y., Chen, K., Zhang, N., et al. (2025) · Advanced Science · doi:10.1002/advs.202411985 · Cited by 10
Alammari, A. H., Gerges, S. H., Isse, F. A., & El‐Kadi, A. O. S. (2023) · Drug Metabolism and Disposition · doi:10.1124/dmd.123.001267 · Cited by 9
Tang, J. S., Cait, A., Li, Y., Abolins-Thompson, H., Gell, K., Herst, P. M., O’Sullivan, D., & Gasser, O. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c02095 · Cited by 9
Microbial tryptophan catabolism as an actionable target via diet-microbiome interactions
Huang, Z., Wells, J. M., Fogliano, V., & Capuano, E. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2369947 · Cited by 9
Potential role of microbes in antigen-based food sensitivities
Caminero, A., Sánchez‐Martínez, E., Wulczynski, M., Moreno‐Serna, L., Verdu, E. F., & Jiménez‐Saiz, R. (2025) · Seminars in Immunology · doi:10.1016/j.smim.2025.101982 · Cited by 7
Hu, W., Naimi, S., Trainel, N., Moal, V. L.-L., Perlemuter, G., Chassaing, B., Ciocan, D. M., & Cassard, A. (2024) · npj Biofilms and Microbiomes · doi:10.1038/s41522-024-00602-9 · Cited by 7
Yao, S., Xue, S., Li, N., Shi, T., Feng, Y., Maimaiti, M., Maimaitireyimu, A., Halike, H., & Gao, F. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1636007 · Cited by 7
Niu, H., Zhou, X., Liu, P., Wu, Y., Lyu, L., Liu, T., Zhang, Z., Zhang, J., Chen, S., Gong, P., et al. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200530 · Cited by 7
Gut dysbiosis: cause or consequence of intestinal inflammation in celiac disease?
Leo, S., Leonard, M. M., Valitutti, F., & Fasano, A. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2483406 · Cited by 6
“A lower production of such molecules following a low-tryptophan uptake has been shown to increase intestinal inflammation in CeD [16].”
Intestinal microbiota and dysbiosis in celiac disease
Sitkin, S. I., Avalueva, E. B., Oreshko, L. S., & Хавкин, А. И. (2021) · Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) · doi:10.21508/1027-4065-2021-66-2-116-122 · Cited by 7
Kanmani, P., Villena, J., Lim, S.-K., Song, E., Nam, Y., & Kim, H. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400227 · Cited by 5
Tian, H., Wang, L., Hardy, R., Kozhaya, L., Placek, L., Fleming, E. S., Oh, J., Unutmaz, D., & Yao, X. (2024) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.3c00386 · Cited by 4
Vacca, M., Celano, G., Nikoloudaki, O., Speckmann, B., Calabrese, F. M., Gobbetti, M., & Angelis, M. D. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250033 · Cited by 6
Connecting coeliac disease to the AhR pathway
Ray, K. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00388-z · Cited by 5
Manipulation of the gut microbiome in gluten-intolerance
Olivares, M., Flor‐Duro, A., & Sanz, Y. (2021) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000791 · Cited by 5
Rondeau, L. E., da Luz, B. B., Haas, D. A., Muppidi, P., Wang, X., Dang, R., Rueda, G. H., Nardelli, A., Palma, G. D., Sokol, H., et al. (2026) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2026.101811 · Cited by 5
“17 18–21 Microbial tryptophan metabolism has been shown to be crucial for intestinal homeostasis and the modulation of mucosal immune responses.”
InfluentialDuffey, H. E., Hedin, K. A., Gelli, H. P., Vaaben, T. H., & Sommer, M. O. A. (2026) · iScience · doi:10.1016/j.isci.2026.115706 · Cited by 17
Koren, O., Collado, M. C., Chassaing, B., Silverman, M. A., & Konnikova, L. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117556 · Cited by 7
From signals to systems: the epigenetic-microbiome-mitochondrial axis in IBD pathogenesis
Kazemifard, N., Shahrokh, S., Dimitrov, G., Totonchi, M., & Dimitrov, S. I. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2692755 · Cited by 4
Is the microbiome important in celiac disease?
Galipeau, H. J., & Verdu, E. F. (2025) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwae047 · Cited by 4
“46 In mice expressing human HLA-DQ8, a low tryptophan diet was associated with reduced indoles, reduced AhR activity in the small intestine, as well as increased paracellular permeability, altered IELs and more severe gluten-immunopathology.”
What Gastroenterologists Should Know About Microplastics and Nanoplastics
Ali, S., Peña, A. N., Lafazanos, Y. S., & Ehrenpreis, E. D. (2024) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000002085 · Cited by 5
Gut mucosal immune responses – Implications for celiac disease and food allergy
Abadie, V. (2025) · Seminars in Immunology · doi:10.1016/j.smim.2025.101984 · Cited by 4
Xue, S., Shi, T., Xie, J., Liu, W., Yao, S., Li, N., Liu, H., Kong, W., & Gao, F. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06991-5 · Cited by 3
“The essential amino acid tryptophan is difficult to metabolize by microorganisms in the duodenum of CeD patients, leading to impaired activation of aryl hydrocarbon receptors in the intestinal mucosa and subsequent inflammation [21].”
Huan, Y., Zhang, W., Xue, L., Tang, Q., Wang, Y., Xu, J., & Xue, C. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107547 · Cited by 3
Toward indole postbiotics precision therapy via AI-powered drug delivery technologies
Puccetti, M., Pariano, M., Anna, W. P., Maurizio, R., & Giovagnoli, S. (2025) · Current Opinion in Immunology · doi:10.1016/j.coi.2025.102692 · Cited by 4
Bantavi, V., Gloeck, L., Leven, P., Zafeiropoulou, K., Welting, O., Sengül, H., Efferz, P., Schneiker, B., McCulloch, T. R., Wilhelm, C., et al. (2026) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2026.101756 · Cited by 3
“11 Pre-and perioperative dietary interventions have been a major consideration among surgeons, and one human study has shown an association between higher habitual preoperative dietary fiber intake and lower risk of postoperative complications in patients with CRC. 49 However, although a healing…”
InfluentialThe immune and microbial homeostasis determines the Candida –mast cells cross-talk in celiac disease
Renga, G., Pariano, M., D’Onofrio, F., Pieraccini, G., Serio, C. D., Villella, V. R., Abbate, C., Puccetti, M., Giovagnoli, S., Stincardini, C., et al. (2024) · Life Science Alliance · doi:10.26508/lsa.202302441 · Cited by 3
Tian, Y., Gao, J., Yuan, J., Yin, Z., Chen, X. D., Wu, Y., Dai, R., Yan, D., Chen, H., & Wu, Y. (2025) · Food & Function · doi:10.1039/d4fo05757k · Cited by 3
Yang, Y., Yang, J., Tang, H., Chen, Y., Gao, Z., Hu, Z. B., Zhuo, X., & Xu, W. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106770 · Cited by 3
Cao, Y. Z., Xiao, S., He, B., Shi, X., Xiao, N., Liu, X., Liu, D., Zhou, Z., & Wang, P. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c02749 · Cited by 5
Bacteria: Potential Make-or-Break Determinants of Celiac Disease
Roque, A., & Pereira, S. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042090 · Cited by 4
“A study found that these patients had less AhR ligands in stool, and their intestinal microbiota had a decreased effect on activating this receptor when compared with non-celiac individuals [47].”
BackgroundLu, M., Feng, R., Liu, Y., Qin, Y., Deng, H., Xiao, Y., & Yin, C. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.990483 · Cited by 3
“Studies have shown that CeD is influenced by the intestinal microbiota (Lamas et al., 2020), and the associated GFD treatment also affects the composition of the intestinal microbiota and its metabolites (Zafeiropoulou et al.”
BackgroundMetabotherapy for intestinal disease: using metabolites to prevent and treat disorders of the gut
Liu, S., Domingo‐Vidal, M., Madhu, B., Binyamin, D., Thaiss, C. A., & Levy, M. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-026-01178-9 · Cited by 5
“In immune cells, such as macrophages and T cells, microbial metabolites influence metabolic reprogramming, shaping immune responses by shifting cells between glycolytic and oxidative states.”
Gut-derived uremic toxin indoxyl sulfate and aryl hydrocarbon receptor in renal osteodystrophy
Russell, C. R., Chen, N. X., Biruete, A., Allen, M. R., Metzger, C. E., Wallace, J. M., & Moe, S. M. (2026) · Biochimie · doi:10.1016/j.biochi.2026.05.009 · Cited by 2
Tryptophan metabolites and the microbiome-gut-brain axis in major gut disorders
Gașpar, B. S., Profir, M., & Creţoiu, S. M. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1004564 · Cited by 2
Tryptophan catabolism by gut microbiota : A bridge connecting food science and human nutrition
Huang, Z. (2023) · doi:10.18174/583090 · Cited by 2
Elucidating the role of microbes in celiac disease through gnotobiotic modeling
Caminero, A., Verdu, E. F., & Galipeau, H. J. (2023) · Methods in cell biology · doi:10.1016/bs.mcb.2023.01.017 · Cited by 1
Towards personalized microbial therapies for metabolic alterations in celiac disease
Borrego-Ruiz, A., & Borrego, J. J. (2025) · Exploration of Digestive Diseases · doi:10.37349/edd.2025.100584 · Cited by 1
Bakhtiari, S., Asri, N., Masotti, A., Jahani‐Sherafat, S., Rezaei–Tavirani, M., & Rostami‐Nejad, M. (2025) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2025.2551656 · Cited by 1
“…with high levels of Trp has been demonstrated to stimulate the production of aryl hydrocarbon receptor ligands, which play a pivotal role in activating anti-inflammatory pathways, strengthening intestinal barrier integrity, and mitigating gluten-induced immunopathology in CD models [89].”
The hologenome in brain health and disease
Dooling, S. W., & Costa‐Mattioli, M. (2025) · Neuron · doi:10.1016/j.neuron.2025.10.039 · Cited by 2
Pesi, A., Lange, S., Schmitt, F. C., Neerukonda, M., Wiegel, M., Petridou, T., Ubbens, H., Strohm, L., Mihaliková, D., Kuntić, I., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-45481-6 · Cited by 1
“However, kynurenic acid can undergo a pathway involving kynurenin-3-monooxygenase (KMO) and kynureninase (KYNU) to produce neurotoxic quinolinic acid, subsequently initiating the release of ROS which are usually detrimental if released at cardiovascular sites 42,43 .”
Aryl hydrocarbon receptor pharmacology—mechanisms, ligands, and therapeutic potential
Bobrovs, R., Olafsen, N. E., Åhrling, S. S., & Matthews, J. B. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100146 · Cited by 2
Reacciones adversas a los alimentos: ¿Cuál es el papel de los microorganismos?
Caminero, A. (2021) · Acta gastroenteorológica latinoamericana/Acta gastroenterológica latinoamericana · doi:10.52787/ntec5426 · Cited by 1
“Así mismo, indoles derivados del triptófano reducen procesos de sensibilización al gluten en estudios preclínicos a través del receptor de los hidrocarbos arilo.(84) Por otro lado, diferentes factores ambientales, dentro de los que se incluyen a los microorganismos, tienen la capacidad de romper esta respuesta inmune…”
BackgroundTherapeutic targets based on the modulation of immune function by gut bacteria
Caminero, A., & Verdu, E. F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821594-4.00004-9 · Cited by 1
Akkerman, R. (2021) · doi:10.33612/diss.195812252 · Cited by 1
Ejes inflamatorios y alarminas en el intestino delgado en enfermedad celíaca
Pérez, F. (2021) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/129881
Probióticos en enfermedad celíaca: ¿estamos listos para su aplicación en la práctica clínica?
Rueda, G. H., & Pinto-Sánchez, M. I. (2021) · Acta gastroenteorológica latinoamericana/Acta gastroenterológica latinoamericana · doi:10.52787/gqme9827
Lamas, B., Evariste, L., & Houdeau, É. (2022) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2022.09.003
Rosacea and associated medical disorders
Paley, E. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19122-0.00009-1
Gut Microbiota Links With Disease
Ishiguro, E. E., Haskey, N., & Campbell, K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91387-4.00009-0
Impact du catabolisme intestinal du Tryptophane dans les maladies inflammatoires
Laurans, L., & Taleb, S. (2024) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2024.03.001
Tian, Y., Gao, J., Yuan, J., Tong, P., Yu, H., Yin, Z., Cheng, Y., Yang, X., Yu, C., Wu, Y., et al. (2025) · Journal of Food Science · doi:10.1111/1750-3841.70234
Kim, H., Kim, H., Lee, Y., Park, C.-H., Cho, B., Son, S. Y., Kim, H.-Y., Kim, G., Park, J., & Park, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411804
“L. reuteri is known to produce indole metabolites that activate the aryl hydrocarbon receptor (AhR), suppress intestinal [26] and neuroinflammation, and improve cognitive performance [27].”
Dialogue entre le microbiote intestinal et l'hôte via le métabolisme du L-tryptophane
Modoux, M. (2022) · theses.fr (ABES) · doi:10.70675/e7e50c6bz7d58z452fzb065z884298a05c4a
Dubois, C. (2022) · theses.fr (ABES) · doi:10.70675/278ccceczff8cz4de1zafcdzcca6580b87d2
Guégan, N. (2024) · theses.fr (ABES) · doi:10.70675/ec31ff94zb0e6z403ez9f71zfa026392bcb2
Bahman, F., Kochumon, S., Madhoun, A. S. A., Al-Roub, A., Bennakhi, A., Arouj, M., Al‐Mulla, F., & Ahmad, R. (2026) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70181
Dysregulation of the Gut-Immune Axis in Acute Pancreatitis and Advances in Its Regulatory Mechanisms
黄, 家. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1662341
Decoding gut microbiome alterations in celiac disease: Implications for pathogenesis and treatment
Fousekis, F., Lianos, G. D., Stavropoulou, E., Patrikiou, E., Vradelis, S., Cassimos, D. C., & Tsigalou, C. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.104127 · Cited by 1
Cheng, S., Xue, S., Xie, J., Feng, Y., Shi, T., & Gao, F. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1915319
Bi, Y., Song, W., Glymenaki, M., Hu, J., Li, X., Huang, H., Peng, Y., Ni, S., Haonon, O., Liu, Z., et al. (2026) · iMeta · doi:10.1002/imt2.70144 · Cited by 1
Shi, P., He, X., Zhao, L., Weisong, P., Zhou, M., & Zhang, T. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1891172
Tohumcu, E., Puca, F. S., Tunalı, V., Cerrito, L., Pallozzi, M., Stella, L., Maestri, M., Murace, C. A., Porcari, S., Varca, S., et al. (2026) · Nutrients · doi:10.3390/nu18172849
“Additionally, the administration of AhR ligand producers L. reuteri, and pharmacological stimulation using a direct ligand of AhR like 6-formylindolo carbazole (Ficz), showed the same effects [68].”
Metabolic shifts driven by host‐microbial interactions
Nair, T., Stuhr, N. L., Weathers, B. A., & Curran, S. P. (2026) · FEBS Journal · doi:10.1111/febs.70704
Роль триптофана при целиакии: обзор литературы
Хавкин, А. И., Nalyotov, A. V., & Sitkin, S. I. (2026) · Children s medicine of the North-West · doi:10.56871/cmn-w.2026.20.41.005
Emerging links between gut dysbiosis, aryl hydrocarbon receptor activation, and Parkinson’s disease
Aziz, N. F., & Kortagere, S. (2026) · Communications Biology · doi:10.1038/s42003-026-11156-1
Metadata
- Authors
- Lamas, B., Hernandez-Galan, L., Galipeau, H. J., Constante, M., Clarizio, A., Jury, J., Breyner, N. M., Caminero, A., Rueda, G., Hayes, C. L., McCarville, J. L., Bermudez Brito, M., Planchais, J., Rolhion, N., Murray, J. A., Langella, P., Loonen, L. M. P., Wells, J. M., Bercik, P., Sokol, H., & Verdu, E. F.
- Affiliations
- McMaster University (CA)
- Farncombe Family Digestive Health Research Institute, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
- AgroParisTech (FR)
- Inserm (FR)
- Mayo Clinic (US)
- Wageningen University & Research (NL)
- Corresponding author
- Lamas, Bruno
- Sokol, Harry
- Verdu, Elena F.
- ORCID
- Lamas, Bruno
- Galipeau, Heather J.
- Constante, Marco
- Clarizio, Alexandra
- Jury, Jennifer
- Breyner, Natalia M.
- Caminero, Alberto
- Rueda, Gaston
- Hayes, Christina L.
- McCarville, Justin L.
- Planchais, Julien
- Rolhion, Nathalie
- Murray, Joseph A.
- Langella, Philippe
- Loonen, Linda M. P.
- Wells, Jerry M.
- Bercik, Premysl
- Sokol, Harry
- Verdu, Elena F.
- Venue
- Science Translational Medicine
- Published
- 2020-10-21
- Volume
- 12
- Issue
- 566
- Pages
- eaba0624
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W3094545640
- Cited by
- 179
- References
- 59
- Citations by year
- 2026: 20 · 2025: 26 · 2024: 33 · 2023: 27 · 2022: 43 · 2021: 27 · 2020: 3
- FWCI
- 21.72
- Type
- journal article
- Language
- en
- Open access
- green
- research.wur.nl
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion)
- HAL (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Joint Programming Initiative A healthy diet for a healthy life (ANR-15-HDIM-0001-1, JPI-HDHL 50-52905-98-601)
- Canadian Institutes of Health Research (CIHR-143922, 168840)
- Topics
- Health Sciences › Medicine › Gastroenterology › Celiac Disease Research and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- aryl hydrocarbon receptor, celiac disease, gut microbiota, intestinal inflammation, gluten, FICZ, fecal microbiota, immunopathology
- MeSH terms
- Gastrointestinal Microbiome, Animals, Celiac Disease, Humans, Inflammation, Ligands, RNA, Ribosomal, 16S, Receptors, Aryl Hydrocarbon, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
